Literature DB >> 4717153

The transport of L-tryptophan from cerebrospinal fluid in the dog.

C Geddes, M J Martin, A T Moir.   

Abstract

1. Endogenous tryptophan is uniformly distributed in dog cerebrospinal fluid (c.s.f.) and is about one tenth of the normal fasting plasma level.2. Using a recirculatory ventriculo-cisternal perfusion technique in conscious dogs it was found that L-tryptophan was removed from c.s.f. by a non-saturable mechanism in addition to bulk absorption of c.s.f. The clearance of L-tryptophan from c.s.f. was unaffected by thiopentone anaesthesia.3. Dialysis of dog plasma against an artificial c.s.f. solution containing L-tryptophan demonstrated that a large proportion of the tryptophan in dog plasma was protein-bound and that the unbound diffusible proportion would equilibrate with tryptophan concentrations equivalent to those normally found in dog c.s.f.4. Use of an open-circuit ventriculo-cisternal perfusion system in unanaesthetized dogs revealed the presence of a saturable component in the transport of tryptophan from c.s.f.5. As [(14)C]L-tryptophan infused into a recirculatory perfusion system produced no radioactively labelled metabolites, it was concluded that removal of tryptophan from c.s.f. by cerebral metabolism does not contribute substantially to maintaining the low levels of tryptophan in c.s.f. but that brain uptake associated with protein-binding may give rise to a small saturable component. The results indicate that the actual concentration gradient of tryptophan between plasma and c.s.f. is much less than it appears from the total concentration of tryptophan in the two fluids, and that the mechanism by which the c.s.f. - plasma distribution of tryptophan is maintained is mainly attributable to simple diffusion.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4717153      PMCID: PMC1350617          DOI: 10.1113/jphysiol.1973.sp010206

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  25 in total

1.  Active transport of Diodrast and phenolsulfonphthalein from cerebrospinal fluid to blood.

Authors:  J R PAPPENHEIMER; S R HEISEY; E F JORDAN
Journal:  Am J Physiol       Date:  1961-01

2.  The binding of L-tryptophan in human plasma at 37 degrees C.

Authors:  R H MCMENAMY; C C LUND; J VAN MARCKE; J L ONCLEY
Journal:  Arch Biochem Biophys       Date:  1961-04       Impact factor: 4.013

3.  Uptake of tyrosine by rat brain in vivo.

Authors:  M A CHIRIGOS; P GREENGARD; S UDENFRIEND
Journal:  J Biol Chem       Date:  1960-07       Impact factor: 5.157

4.  STUDIES OF UNBOUND AMINO ACID DISTRIBUTIONS IN PLASMA, ERYTHROCYTES, LEUKOCYTES AND URINE OF NORMAL HUMAN SUBJECTS.

Authors:  R H McMenamy; C C Lund; G J Neville; D F Wallach
Journal:  J Clin Invest       Date:  1960-11       Impact factor: 14.808

5.  5-hydroxyindole metabolism in rat brain. A study of intermediate metabolism using the technique of tryptophan loading. II. Applications and drug studies.

Authors:  D Eccleston; G W Ashcroft; T B Crawford
Journal:  J Neurochem       Date:  1965-06       Impact factor: 5.372

6.  Transport of lysine from cerebrospinal fluid of the cat.

Authors:  R W Cutler
Journal:  J Neurochem       Date:  1970-07       Impact factor: 5.372

7.  Transport of neutral amino acids from feline cerebrospinal fluid.

Authors:  S R Snodgrass; R W Cutler; E S Kang; A V Lorenzo
Journal:  Am J Physiol       Date:  1969-10

8.  Effects of halothane, trichloroethylene, pentobarbitone and thiopentone on amino acid transport in the perfused rat liver.

Authors:  D L Bloxam
Journal:  Biochem Pharmacol       Date:  1967-09-09       Impact factor: 5.858

9.  The free amino acids of human spinal fluid determined by ion exchange chromatography.

Authors:  J C Dickinson; P B Hamilton
Journal:  J Neurochem       Date:  1966-11       Impact factor: 5.372

10.  Transport of 1-aminocyclopentanecarboxylic acid from feline cerebrospinal fluid.

Authors:  R W Cutler; A V Lorenzo
Journal:  Science       Date:  1968-09-27       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.